M-PREDROL Drug Patent Profile
When do M-predrol patents expire, and when can generic versions of M-predrol launch?
M-predrol is a drug marketed by Bel Mar and is included in two NDAs.
The generic ingredient in M-PREDROL is methylprednisolone acetate. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for M-predrol
A generic version of M-PREDROL was approved as methylprednisolone acetate by EMERGE BIOSCIENCE on February 23rd, 2005.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for M-PREDROL?
- What are the global sales for M-PREDROL?
- What is Average Wholesale Price for M-PREDROL?
Summary for M-PREDROL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Patent Applications: | 5,197 |
| DailyMed Link: | M-PREDROL at DailyMed |
US Patents and Regulatory Information for M-PREDROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bel Mar | M-PREDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 086666-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bel Mar | M-PREDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 087135-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
